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Accepted 17 February 2013AbstractIn daily obstetric practice, oxytocin is one of the most frequently used drugs to stimulate uterine contraction. However, uterine sensitivity to
oxytocin is profoundly different among pregnant women, which may reflect oxytocin receptor (OTR) expression in the uterus. We review here
the literature focusing on OTR regulation in the human uterus. Recent progress in molecular biology has augmented our knowledge about OTR
regulation in the uterus at the transcription level, although the totality of preparation for labor through OTR expression is still obscure.
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After conception and implantation of the embryo, the
uterus remains quiescent until the onset of labor and con-
tractile forces cause expulsion of the fetus. Disorders of timing
of labor onset, either preterm or post-term, may cause severe
damage to the baby. Disorders of the force of labor, either too
weak or too strong, may also cause dystocia, fetal asphyxia, or
uterine rupture and hurt both mother and baby severely.
Therefore, the regulation of timing and force of labor is crit-
ical for the safety of both mother and fetus.
Oxytocin is one of the most potent uterotonic reagents and
is widely used in daily practice to induce or augment labor,
and to treat postpartum hemorrhage. Oxytocin had been
considered to be the major determinant of labor onset from its
ability to induce labor at term; however, its concentration in
maternal blood during the natural course of parturition does
not increase until the second phase of labor [1]. The outrider
works from Soloff et al [2] and Fuchs et al [3] indicate that
oxytocin receptor (OTR) expression drastically increases just* Corresponding author. Department of Obstetrics and Gynecology, Osaka
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tritium-labeled oxytocin both in rat and human myometrium.
These findings suggest that the upregulation of OTR expres-
sion may determine the timing of parturition via increased
bioavailability of oxytocin. In order to prove this hypothesis,
molecular analysis of the OTR may be necessary. It is well
known that the oxytocin-OTR system plays various roles, not
only in the uterus and mammary gland, but also in the central
nervous system, behavioral state, kidney, heart, etc. [4,5]. Our
review here focuses on the OTR regulatory mechanism in the
uterus to stimulate investigation into the physiology of
obstetrics.
Molecular analysis of OTR
In order to investigate the regulatory mechanism of a pro-
tein, it was first recognized that knowledge of its gene struc-
ture is necessary. However, in the early 1990s, there was no
available information or database about OTR-related mole-
cules. It was observed that the content of messenger (m)RNA
encoding OTR in the human uterus at parturition was
extremely high using a Xenopus laevis oocyte expression
system [6]. This system was applied to cDNA library
screening and human OTR cDNA was cloned [7]. Deduced
amino acid sequence indicated that OTR belonged to the G-cs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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showed highest homology to the vasopressin V1a, V1b, and
V2 receptors, which are now termed the nonapeptide hormone
receptor family because oxytocin and vasopressin are highly
homologous peptide hormones consisting of 9-amino acids.
Using this cDNA as a probe, human OTR gene was investi-
gated [8]. This gene spans approximately 17 kb, contains 3
introns and 4 exons, and located in chromosome 3p26.2. After
the initial work, the gene structures of OTR were identified in
other species such as rats [9], cattle [10] and mice [11], and
their structures were compared (reviewed in [12]). Using this
cDNA, it was confirmed that mRNA from human term uterine
myometrium contains a large amount of OTR message. As this
result paralleled the amount of OTR protein by western blot-
ting, it was speculated that OTR expression was mainly
regulated at the transcription level [13]. It was also determined
that the expression of OTR increased after onset of labor as
well as during the course of parturition in decidua [14]. It has
been reported that oxytocin peptide itself is also produced in
decidua and is increased after onset of labor [15]. Moreover,
oxytocin stimulates prostaglandin secretion from human
decidua [16] and prostaglandin levels in maternal plasma after
successful induction by oxytocin were significantly higher
than in those who failed to respond to oxytocin [17]. Taken
together, there may be an oxytocin autocrineeparacrine circuit
system in decidua and myometrium to induce and facilitate
labor in situ. It makes sense that plasma oxytocin levels do not
alter prior to the onset of labor if this system is mainly
regulated within decidua in situ. Increased mRNA levels
encoding OTR and other uterine activation proteins such as
cyclooxygenase-2 (COX-2) or PGF2a receptor (FP) in decidua
after onset of labor was observed in the uterine tissues during
term and preterm labor [18], suggesting that the basic regu-
lation for uterine activation was similar between term and
preterm labor.
A recent report indicated that there was no difference in
OTR mRNA expression between not-in-labor and in-labor
myometrium [19]. However in this report, myometrium was
obtained from cesarean delivery incision sites, equivalent to
the lower segment of the uterus. As the gene expression
pattern is very different between the fundus and lower segment
of the uterus at parturition [20] and as the lower segment is
often extended at term of pregnancy, this result might be
caused by a sampling effect.
Regulation of OTR by estrogen
OTR is induced by estrogen. In rats and sheep, females
whose ovaries had been removed lost the receptor expression
and supplementation of estrogen recovered its expression in
the brain and uterus. In late pregnancy rats, administration of
tamoxifen, a selective estrogen receptor modulator, attenuated
OTR expression in myometrium [21]. The upstream of the
OTR genes was cloned in several species. In rats there is an
incomplete palindromic estrogen responsive element sequence
(ERE) 4 kb upstream of the gene [22]. The function of this
element under estradiol treatment is obscure. All of the OTRgene upstream sequences contain several half sites of ERE,
and tandem half sites of ERE are functional in the chicken
ovalbumin gene [23]. However, when estrogen receptor (ER)a
and reporter gene were cotransfected with human OTR up-
stream up to 7 kb into HeLa cells, no transactivating activity
for estradiol was observed (T. Kimura, unpublished data). The
OTR gene of many species contains not only ERE-half sites,
but also SP-1 sites, nuclear factor (NF)-interleukin (IL)6
binding sites, stat-3 binding sites, AP-1 sites, etc. Telgmann
et al made reporter constructs far upstream of the bovine OTR
prompter region (up to 3.2 kb). Although they noticed other
ERE-half sites in the far upstream region, estradiol did not
show any effect on OTR expression in an ovine glandular
epithelial cell line, which expresses endogenous ERs. After
cotransfection with cyclic AMP response element binding
protein-binding protein cDNA and SRC1 and/or SRC2
cDNAs, estradiol revealed significant transactivation activity
[24]. The authors did not determine specific sequence ele-
ments that affect the estrogen transactivation. Precise inter-
action between OTR gene, ERa and these cofactors remains to
be elucidated. In the ovine (sheep) model, short OTR promoter
(up to 220 bp) revealed basal promoter activity and estrogen
dependency under cotransfection with ovine ERa. When GC-
rich SP-1 binding elements of the OTR gene were mutated,
enhancement of promoter activity by estradiol was abolished.
There was no ERE-half site within this region. Instead, it was
noticed the progesterone receptor element half sites. Indeed
when progesterone receptor (PR)B cDNA (see below) was
cotransfected and stimulated with progestin, OTR promoter
activity was facilitated [25]. This observation appears to be
different from the physiological scenario, in which progestin
usually suppresses OTR expression. In myometrium of relaxin
(Rlx) knockout mice, both OTR and ERa expression were
attenuated in late pregnancy [26], although pregnant female
Rlx/ mice gave birth normally. It is obvious that estrogen
facilitates uterine OTR expression in vivo, although it appears
not to be a direct effect. In term myometrium, rapid turnover
of ERa protein was reported. When myometrial explants were
stimulated by estradiol, extracellularly regulated kinase
(ERK1/2) phosphorylation was observed, and phosphorylated
ERK1/2 induced OTR mRNA expression [27]. This report did
not reveal direct interaction between ERKs and the OTR gene.
Any complex transcriptional machinery or nongenomic effects
between estrogen and OTR should be further elucidated.
Regulation of OTR by progesterone
Progesterone acts to maintain uterine quiescence during
pregnancy. Indeed, pregnant women with high risk of preterm
birth can be effectively treated by progestin administration
(reviewed in [28]). In rodents, luteolysis and progesterone
withdrawal during pregnancy caused parturition. In sheep,
increased cortisol from fetal adrenal gland steeply increased
the estrogen/progesterone ratio in maternal blood via placental
metabolism, and caused parturition (reviewed in [29]).
However in humans, progesterone withdrawal occurs after
delivery of the placenta [30], which is the major source of
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and PRB. PRA is the short truncated form of PRB and works
as the dominant transactivation repressor of PRB in the pres-
ence of progestin. In human myometrium, PRA expression
was reported to be higher after the onset of labor [31].
Induction of PRA protein functions may act as a progesterone
withdrawal effect. In a nonlabor biopsy sample of human
myometrium taken during cesarean delivery, the PRA/PRB
mRNA ratio clearly correlated to the amount of ERa, COX-2,
as well as to OTR mRNAs determined by quantitative RT-PCR
[32]. It also strongly suggests that “functional” progesterone
withdrawal in human myometrium regulates the OTR and
other uterine activation proteins.
Another consideration is the anti-inflammatory effect of
progesterone. RelA (p65), a component of NFkB, which is the
representative NF mediating inflammatory events to gene
transcription, directly interacts with PRB and PRA. Tumor
necrosis factor (TNF)-a induced NFkB-mediated trans-
activation was attenuated by PRB, and progesterone induced
PRB transactivation was repressed by TNF-a induced NFkB
[33]. These transrepression effects of NFkB and PRB may also
explain functional progesterone withdrawal. Plenty of clinical
and experimental findings have shown the interaction between
inflammation and uterine contraction. In the mouse model,
administration of proteasome inhibitor to attenuate NFkB
activation could delay the onset of antiprogestin-induced pre-
term birth [34]. This observation also suggests the interaction of
PR function andNFkB in vivo. The transrepression theory of PR
and NFkB is very attractive to explain functional progesterone
withdrawal and uterine activation at parturition.
Recently, microRNAs (miRs) are considered to be another
modulator for many genes. In mouse and human myometrium,
miR-200 family members are increased at term and proges-
terone withdrawal by antiprogestin-induced miR-200 family
expression. The miR-200 family interacts with mRNAs for
ZEB1 and ZEB2, which are zinc-finger E-box-binding
homeobox proteins, and act as transcriptional repressors,
downregulating ZEB1 and ZEB2 expression. ZEB1 and ZEB2
inhibit the expression of the contraction associated protein
genes including OTR [35]. Although there is no direct proof
that the ZEB proteins interact with the OTR gene, upregula-
tion of miR-200 family microRNAs by progesterone with-
drawal facilitates uterine contraction. This observation might
explain another pathway for how progesterone regulates
uterine activity during pregnancy.
Inflammation, mechanical stimuli and the OTR
Causes of preterm birth are complex; however, clinical and
experimental data indicate that infections (chorioamnionitis,
intrauterine infection, and general infections such as pyelo-
nephritis or pneumonia) and overstretching of the uterine wall
(multiple pregnancy, polyhydramnios) could induce preterm
birth. After cloning of the OTR gene promoter, researchers
focused on the existence of tandem acute phase response
element (now termed stat-3), NF-IL-6 and activator protein-1
consensus sequences and hypothesized their function atinflammatory stimuli. When IL-1b and IL-6 were applied to a
myometrial cell line (ULTR), OTR mRNA level was
decreased. CAT reporter activity, with the gene construct of
the human OTR gene promoter region (1203/þ108), was
attenuated by IL-1b and IL-6, although NF-IL-6 was induced
in the nucleus of ULTR cells [36]. This observation was un-
expected from clinical viewpoints and several other experi-
ments were performed. It was reported that IL-1b decreased
and IL-6 increased OTR mRNA expression [37e39], but a
direct interaction between cytokine-induced nuclear factors
and the OTR gene was not revealed. Using myometrial cell
culture obtained from cesarean delivery, IL-1b revealed a
biphasic effect on OTR expression, i.e., OTR was upregulated
after 4 hours and downregulated after 20 hours. NFkB and
CCAAT/enhancer-binding protein-b (C/EBPb) were activated
after 4 hours of IL-1b stimulation, and they bound to NFkB
and C/EBPb binding sites in the OTR gene promoter.
Cotransfection of NFkB p65 (RelA) and C/EBPb massively
activated the reporter activity with the OTR promoter [40].
RelA and C/EBPb interact each other in the nucleus and they
bind together to the binding 20-bp element of 712 to 692
of the human OTR gene promoter [41].
Mechanical stretching of the human myometrial strip ob-
tained during cesarean delivery before onset of labor,
enhanced OTR mRNA expression. This stretching effect was
abolished in similar samples obtained after onset of labor,
probably because they were already stimulated by natural
stretching due to labor. In vitro stretching of cultured human
uterine myocytes activated AP-1, C/EBPb, but not NFkB.
Transfection of C/EBPb cDNA into myocytes augmented OTR
promoter activity in cultured myocytes, but AP-1 did not affect
the OTR promoter [42].
Taken together, inflammatory and stretch signals may
stimulate OTR promoter activity via C/EBPb; however, these
effects have only been revealed by cotransfection type
experiments.
Term myometrium-specific OTR gene binding protein:
Differential protein-DNA binding analysis
In order to determine the myometrium-specific OTR upre-
gulation mechanism at term, another straightforward strategy is
comparison of DNA binding protein profile extracted from
nonpregnant and term pregnant myometrium to the OTR pro-
moter region. Nuclear proteins from nonpregnant and term
myometrium were at first compared by gel-shift assay with a
series of OTR promoter fragments, and shifted signal were
further analyzed bymethylation interference footprinting assay.
Two binding elements that were not related to known nuclear
protein-binding sites were investigated. The first element, US-1,
was located within 1745 to 1729 bp of the human OTR
promoter and showed enhancer activity. However, the study
failed to identify a binding protein by a batch purification
procedure [43]. The second element, US-2 (1433 to1414 bp
of human OTR promoter), was applied to yeast one hybrid
system as a bait and a cDNA library from human term myo-
metrium was screened. A 2.3-kb full-length cDNA encoding a
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cDNA encodes an 18 kDa protein containing an extended basic
leucine zipper (bZip) structure, but lacking a transactivation
domain. hMafF mRNA and protein were detected in term
myometrium and kidney, but not in nonpregnant myometrium
or first-trimester myometrium [44]. Proteins containing a bZip
structure interact with various families of transcription factors
to activate or repress target gene expression. Ye et al used a
novel human protein (GenBank AF289559), containing a
coiled-coil domain of 48 amino acid residues with a typical
heptad repeat of leucines, as bait for yeast two-hybrid screening
and screened a human placental cDNA library. Interestingly,
they isolated hMafF cDNA and named the bait protein they used
as MafF interacting protein (MIP). MIP physically interacts
with hMafF protein. Cotransfection of MIP and hMafF cDNA
enhanced promoter activity containing a multiple US-2 element
repeated sequence in HeLa cells and in yeast [45,46]. However,
there is neither proof of MIP existence in human term myo-
metrium, nor functional analysis of MIP and hMafF on the OTR
promoter as yet. Small Maf proteins including MafF are
considered to heterodimerize with Nrf (NFE2 related proteins)
family transcription factors andmodulating the activity of genes
carrying antioxidant regulatory elements [47]. Some of them
relate to a chemoprotective system against carcinogens. Murine
MafF knockout mice did not reveal any novel phenotypes
including reproductory dysfunction [48]. Therefore, the actual
function of MafF on parturition should be further examined.
Epigenetic modulation of the OTR gene
In the human OTR gene, there is a long CpG island
140 bp to þ2383 bp. Within this CpG island, the geneFig. 1. Hypothesis for oxytocin receptor regulation. Oxytocin receptor is drastical
metrial RNA). The mechanism of transcriptional regulation has been widely invesmethylation level of the 405 bp fragment (MT2) was highest in
liver compared to nonpregnant and term myometrium. A he-
patocellular carcinoma cell line (HepG2) was cultured with
5-azacytidine to demethylate genomic DNA. HepG2 cells
originally expressed minimal OTR mRNA and its expression
level was upregulated after demethylation treatment. OTR-
reporter gene plasmids were enzymatically methylated
in vitro and transfected into HepG2 cells. When the plasmid
contained the MT2 region, it showed the highest suppression
of reporter activity. Therefore, methylation of the MT2 region
has a significant effect on transcription of the OTR gene [49].
Recently, the relationship of OTR deficiency in the brain and
autism has been extensively examined. There is a report that
aberrant methylation of this MT2 region is observed in the
DNA extracted from cortex of autistic patients, which might
relate to the shortage of OTR expression in the patients’ brains
[50]. The OTR gene contains a large intron, and gene
methylation status within this intron 3 may also regulate tissue
specific transcriptional suppression [51]. Modification of the
OTR gene by methylation may permit its tissue specific
expression in the body.
Summary
There is plenty of information about OTR regulation;
however, none of it explains direct and straightforward phys-
iological regulation of OTR at parturition at the molecular
level. Pharmacological experiments suggest that oxytocin-
induced myometrial contractions might be modulated by
contractile machinery rather than the quantity of OTR [52].
Pregnant mice deficient for the receptor prostaglandin F2a
express lower levels of OTR. However, they successfullyly upregulated during the course of pregnancy (see northern blotting of myo-
tigated, although not all studies are conclusive.
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higher dose [53]. These results might reflect the complex
regulation of OTR-contraction mechanism in vivo. Oxytocin
and OTR knockout mice delivered their pups without any
problems [54e56], suggesting that the oxytocin-OTR system
is not essential for parturition. These animal models revealed
social behavior deficits, and recent research into the oxytocin-
OTR system focuses on neuroscience, rather than obstetrics.
Phenotypes of knockout model mice are often covered by
redundancy. Indeed, it is reported that the genotype of OTR in
humans may predict the length of the first stage of labor [57].
Drastic upregulation of OTR in myometrium at parturition
suggests that molecular analysis of OTR regulation in myo-
metrium may be a good probe for understanding parturition
(Fig. 1). We expect that via investigation of molecular
mechanism of OTR regulation, we could find the molecular
target to cure preterm birth as well as diseases from abnormal
uterine contractions.
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